Updates are available Correction dated 2023-02-16
Click to view Correction: https://doi.org/10.1007/s00417-023-06011-6
-
Authors
Riemer, Tommes
Berndt, Dominique
Böker, Alexander
Lehmann, Josefine
Schrifl, Ulrike
Rau, Saskia
Rübsam, Anne
Joussen, Antonia M.
Zeitz, Oliver http://orcid.org/0000-0003-4115-7728
-
Funding
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 25 July 2022
Revised: 17 November 2022
Accepted: 21 December 2022
First Online: 12 January 2023
Change Date: 16 February 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00417-023-06011-6
Declarations
:
: All data handling was done within the safeguarded Charité IT environment to comply with data protection law. The study was approved by the ethics committee of Charité (reference number: EA1/085/20) and has been reviewed by the data protection committee of Charité.
: Consent for use of data was obtained from each patient.
: Oliver Zeitz received personal fees from Bayer AG, grants from Novartis, personal fees from Boehringer Ingelheim, outside the submitted work.Antonia M. Joussen received consulting fees and speaking Honoria from Bayer AG, Novartis, Roche and Böhringer Ingelheim.Alexander Böker received speaking honoria from Novartis.Anne Rübsam received speaking honoria from Bayer Healthcare and Novartis and served as consultant for Novartis.Saskia Rau received speaking honoria from Bayer Healthcare, Novartis and Allergan/AbbVie.
